Free Trial
→ What's the Best Way to Lower RMD Taxes? (From SmartAsset) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LadRx Corp stock logo
CYTR
LadRx
$0.09
$0.05
▼
$0.86
$4.14MN/A99,706 shs4,000 shs
ETHZ
Flag Ship Acquisition
$2.31
-4.5%		$0.00
$0.66
▼
$17.75
$13.95M0.3730.01 million shs8.03 million shs
FLN
First Trust Latin America AlphaDEX Fund
$20.97
+1.5%		$19.74
$15.03
▼
$21.39
$16.78M1.097,911 shs1,765 shs
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$28.23
+0.9%		$26.86
$23.28
▼
$29.69
$15.54M0.77,123 shs4,285 shs
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LadRx Corp stock logo
CYTR
LadRx
0.00%0.00%0.00%0.00%0.00%
ETHZ
Flag Ship Acquisition
-4.55%+230,999,900.00%+230,999,900.00%+230,999,900.00%+230,999,900.00%
FLN
First Trust Latin America AlphaDEX Fund
+1.55%+2.39%+7.54%+7.70%+15.28%
FTXH
First Trust Nasdaq Pharmaceuticals ETF
+0.98%+1.95%+8.39%+8.85%-3.57%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LadRx Corp stock logo
CYTR
LadRx
$0.09
$0.05
▼
$0.86
$4.14MN/A99,706 shs4,000 shs
ETHZ
Flag Ship Acquisition
$2.31
-4.5%		$0.00
$0.66
▼
$17.75
$13.95M0.3730.01 million shs8.03 million shs
FLN
First Trust Latin America AlphaDEX Fund
$20.97
+1.5%		$19.74
$15.03
▼
$21.39
$16.78M1.097,911 shs1,765 shs
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$28.23
+0.9%		$26.86
$23.28
▼
$29.69
$15.54M0.77,123 shs4,285 shs
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LadRx Corp stock logo
CYTR
LadRx
0.00%0.00%0.00%0.00%0.00%
ETHZ
Flag Ship Acquisition
-4.55%+230,999,900.00%+230,999,900.00%+230,999,900.00%+230,999,900.00%
FLN
First Trust Latin America AlphaDEX Fund
+1.55%+2.39%+7.54%+7.70%+15.28%
FTXH
First Trust Nasdaq Pharmaceuticals ETF
+0.98%+1.95%+8.39%+8.85%-3.57%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LadRx Corp stock logo
CYTR
LadRx
0.00
N/AN/AN/A
ETHZ
Flag Ship Acquisition
0.00
N/AN/AN/A
FLN
First Trust Latin America AlphaDEX Fund
0.00
N/AN/AN/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
2.52
Moderate Buy$28.23N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LadRx Corp stock logo
CYTR
LadRx
N/AN/AN/AN/AN/AN/A
ETHZ
Flag Ship Acquisition
N/AN/AN/AN/A$2.91 per shareN/A
FLN
First Trust Latin America AlphaDEX Fund
N/AN/AN/AN/AN/AN/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LadRx Corp stock logo
CYTR
LadRx
N/AN/A0.00N/AN/AN/AN/AN/AN/A
ETHZ
Flag Ship Acquisition
-$6.17M-$15.070.00∞N/AN/A-141.25%-80.77%N/A
FLN
First Trust Latin America AlphaDEX Fund
N/AN/A9.93∞N/AN/AN/AN/AN/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/AN/A14.51∞N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
LadRx Corp stock logo
CYTR
LadRx
N/AN/AN/AN/AN/A
ETHZ
Flag Ship Acquisition
N/AN/AN/AN/AN/A
FLN
First Trust Latin America AlphaDEX Fund
$0.753.58%N/AN/AN/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$0.441.56%N/AN/AN/A

Latest CYTR, FLN, FTXH, and ETHZ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/25/2025
FLN
First Trust Latin America AlphaDEX Fund
Quarterly$0.27095.55%6/26/20256/26/20256/30/2025
6/25/2025
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Quarterly$0.08921.39%6/26/20256/26/20256/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
LadRx Corp stock logo
CYTR
LadRx
N/AN/AN/A
ETHZ
Flag Ship Acquisition
N/A
0.58
0.58
FLN
First Trust Latin America AlphaDEX Fund
N/AN/AN/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
LadRx Corp stock logo
CYTR
LadRx
N/A
ETHZ
Flag Ship Acquisition
4.07%
FLN
First Trust Latin America AlphaDEX Fund
N/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/A

Insider Ownership

CompanyInsider Ownership
LadRx Corp stock logo
CYTR
LadRx
N/A
ETHZ
Flag Ship Acquisition
38.20%
FLN
First Trust Latin America AlphaDEX Fund
N/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
LadRx Corp stock logo
CYTR
LadRx
N/A45.04 millionN/ANot Optionable
ETHZ
Flag Ship Acquisition
76.04 million3.73 millionN/A
FLN
First Trust Latin America AlphaDEX Fund
147,000800,000N/ANot Optionable
FTXH
First Trust Nasdaq Pharmaceuticals ETF
147,000550,000N/AOptionable

Recent News About These Companies

A Look at Pharma ETFs After Strong Q1 Earnings
May 8, 2025  |  zacks.comhttps://www.zacks.com/stock/news/2465362/a-look-at-pharma-etfs-after-strong-q1-earnings?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2465362
First Trust Nasdaq BuyWrite Income ETF declares $0.207 dividend
January 22, 2025  |  msn.comhttps://www.msn.com/en-us/money/investment/first-trust-nasdaq-buywrite-income-etf-declares-0-207-dividend/ar-AA1xGeEp
Pharma ETFs in Focus Post Solid Q2 Earnings
August 14, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2322190/pharma-etfs-in-focus-post-solid-q2-earnings?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2322190
A Look at Pharma ETFs Post Q1 Earnings
May 7, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2269782/a-look-at-pharma-etfs-post-q1-earnings?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2269782
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
April 17, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2256952/jnj-beats-q1-earnings-estimates-misses-on-sales-etfs-in-focus?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2256952
3 Health Care ETFs You'll Want to Own When the Market Recovers
August 3, 2022  |  stocknews.comhttps://stocknews.com/news/ftxh-vht-pph-3-health-care-etfs-youll-want-to-own-when-the/
Surprising Analyst 12-Month Target For FTXH
May 25, 2022  |  nasdaq.comhttps://www.nasdaq.com/articles/surprising-analyst-12-month-target-for-ftxh
First Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0488
March 25, 2022  |  seekingalpha.comhttps://seekingalpha.com/news/3817658-first-trust-nasdaq-pharmaceuticals-etf-declares-quarterly-distribution-of-00488
Solid Q4 Earnings Fail to Impress Pharma ETFs
February 22, 2022  |  nasdaq.comhttps://www.nasdaq.com/articles/solid-q4-earnings-fail-to-impress-pharma-etfs
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
November 9, 2021  |  nasdaq.comhttps://www.nasdaq.com/articles/wave-of-solid-q3-earnings-push-pharma-etfs-higher
4 ETF Strategies to Follow Warren Buffett's Vision
August 19, 2021  |  msn.comhttps://www.msn.com/en-us/money/topstocks/4-etf-strategies-to-follow-warren-buffetts-vision/ar-AANuXxl

New MarketBeat Followers Over Time

Media Sentiment Over Time

LadRx stock logo

LadRx NASDAQ:CYTR

LadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.

Flag Ship Acquisition NASDAQ:ETHZ

$2.31 -0.11 (-4.55%)
As of 09/5/2025 04:00 PM Eastern

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

First Trust Latin America AlphaDEX Fund NASDAQ:FLN

$20.97 +0.32 (+1.55%)
As of 09/5/2025 02:08 PM Eastern

The First Trust Latin America AlphaDEX Fund (FLN) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Latin America index. The fund tracks an index of Latin American firms screened based on a proprietary methodology, using various factors and weighted in tiers. FLN was launched on Apr 18, 2011 and is managed by First Trust.

First Trust Nasdaq Pharmaceuticals ETF NASDAQ:FTXH

$28.22 +0.27 (+0.95%)
Closing price 09/5/2025 03:31 PM Eastern
Extended Trading
$28.22 0.00 (0.00%)
As of 09/5/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas